WESTBROOK, Maine, May 24, 2011 /PRNewswire/ -- IDEXX Laboratories,
Inc. (NASDAQ: IDXX), today announced the appointment of
George Fennell as Corporate Vice
President, General Manager, North American Companion Animal Group
Customer Facing Organization, effective May
31.
Mr. Fennell joins IDEXX from Pfizer, Inc., where he recently
served for five years as Vice President, U.S. Companion Animal
Division of Pfizer Animal Health, leading its overall sales,
marketing and technical operations functions.
"George is a seasoned executive in companion animal healthcare
and brings to our team extensive sales and marketing experience and
great customer insight, making him an excellent fit for this role,"
said Jonathan Ayers, Chairman and
CEO. "As a member of the leadership team at IDEXX, George will play
a key role in driving our continued growth in the North American
companion animal health market through innovation and great
commercial execution."
"I am very excited to be part of the IDEXX team at this time of
incredible opportunity in the animal health market," said Fennell.
"IDEXX's unique market position as a leader in diagnostic and
information technology presents many opportunities to enhance the
practice of veterinary medicine, the health of pets, and the
satisfaction of pet owners."
About IDEXX Laboratories
IDEXX Laboratories, Inc. is a leader in pet healthcare
innovation, serving practicing veterinarians around the world with
a broad range of diagnostic and information technology-based
products and services. IDEXX products enhance the ability of
veterinarians to provide advanced medical care, improve staff
efficiency and build more economically successful practices. IDEXX
is also a worldwide leader in providing diagnostic tests and
information for livestock and poultry and tests for the quality and
safety of water and milk. Headquartered in Maine, IDEXX Laboratories employs more than
4,800 people and offers products to customers in over 100
countries.
Contact: Merilee Raines, Chief
Financial Officer, 1-207-556-8155
SOURCE IDEXX Laboratories, Inc.